Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML
Status:
Recruiting
Trial end date:
2026-06-03
Target enrollment:
Participant gender:
Summary
The Investigators would like to study the incidence of complete remission (CR) at day +30
after Clofarabine followed by haploidentical transplant. The conditioning regimen used is
Fludarabine, Busulfan (2 doses) or cyclophosphamide (2 doses) and Total Body Irradiation
(TBI) with post transplant cyclophosphamide for patients with Acute Myeloid Leukemia (AML)
who are not in remission prior to considering allogeneic transplant with haploidentical
donors.